
Vividion Therapeutics Announces Expansion with New Global R&D Center
Vividion Therapeutics, Inc. (Vividion), a clinical-stage biopharmaceutical company known for its novel discovery technologies targeting high-value, traditionally undruggable targets with precision therapeutics for devastating cancers and immune disorders, announced plans…












